REVOLUTIONARY HEADACHE TREATMENT

What is SPG Block and why should I consider it for my patient?

The sphenopalatine ganglion (SPG) is located just deep to the nasal mucosa posterior to the middle nasal turbinate. The SPG can be blocked by diffusion of local anesthetic through the overlying mucosa. Sensory, sympathetic and parasympathetic fibers pass through or synapse in the SPG, making it a key structure in various types of cephalgia. Temporarily blocking function of the SPG can provide prompt, and sometimes sustained, relief of pain. It is theorized that SPGB provides sustained relief by disrupting dysfunctional neuronal activity, allowing restoration of normal function.

Getting serious about blocking pain.

Currently there is very little to offer the chronic headache patient. Nearly two thirds of patients discontinue prescription medications due to inadequate relief and side-effects.

SPG blocks achieve neuromodulation of the sphenopalatine ganglion complex. This means that the time-tested efficacy of the procedure has been shown to have both immediate and sustained results. These effects are typically sustained by interrupting the chaotic signaling associated with migraine.

Although proven effective, few physicians offer the SPG block to patients because the traditional procedures are uncomfortable and dangerous for the patient and demanding for the care giver. Traditionally, the block is attempted by navigating a cotton tip applicator through the nasal passages and place it there for 30 minutes, or with a long needle through the side of the head. These approaches carry risks and sometimes require sedation.

Today, establishing an SPG block has never been easier. The patented Tx360EU® offers the practitioner the ability to offer a first-line treatment in the chronic headache patient. Tx360EU® delivers medication that can sustain pain relief in a ten to thirty seconds procedure that is comfortable and quick. With Tx360EU®, SPG may be achieved without needles, cotton swabs, atomizer sprays or systemic narcotics.

SPG blocks have time-tested efficacy when it comes to serious chronic and episodic migrainous pain.

SPG Blocks have been performed for centuries, but new technology allows them to be performed with comfort and ease

spgblocktx360

Tx360EU® is a single-use, disposable catheter that delivers medication through the nasal passages to a difficult-to-reach ganglion located at the back of the nose easily, safely, efficiently and accurately (only 0.6cc of medication needed).

When used as indicated, Tx360EU® delivers the medication immediately proximate to the ganglion to achieve a Sphenopalatine Ganglion or SPG block. Interventional radiologists, neurologists, internists, emergency departments and pain specialists are interested in utilizing Tx360EU® for a safe, comfortable and quick delivery of the medication required for the SPG block procedure.

The drug delivery innovation, Tx360EU®, is drawing the attention of physicians who treat patients with chronic and episodic migraine, cluster headache, and chronic daily headache and for other applications. The SPG blocks have been studied for many disorders for over a century. More recently however, the block has been associated with profound neuromodulation of the SPG complex, resetting the chaotic signaling associated with chronic migraine with both immediate and sustained results.

Though widely accepted as effective, few physicians are willing to perform an SPG block because the traditional procedures are uncomfortable for the patient and demanding for the caregiver. Formerly, the block was attempted by navigating a cotton tip applicator through the nasal passages, by atomizing a spray or with a long needle through the side of the head. These older approaches carry risks, sometimes require sedation and may not be effective in all patients.

Headache alone affects nearly 45 million individuals, and migraine occurs in 6.8% of men and 15-18% of women. Nearly two-thirds of headache patients discontinue prescription medications due to inadequate relief and side effects. The SPG block may also have utility in the treatment of other disorders. Tx360EU® is designed to deliver medicines right onto the sphenopalatine foreman in order to block the entire SPG apparatus. Tx360EU® allows easy and accurate placement of medications right onto the sphenopalatine foramen, no imaging guidance is necessary.

PURCHASE

Older Techniques

The past techniques utilized for the nerve block are very unreliable, complicated and painful. SPGB has been described in the medical literature for over 100 years. It has been proven effective for many painful conditions. The main limitation to the procedure has been that it is the discomfort and risks for patients, the inconsistency of medicine placement impacting results. Therefore the clinical use of this therapeutic modality has been much under-utilized at present.

Transnasal Technique:

This technique attempts to drip local anesthetic down the Q-tip to access the SPG. The process takes 25 – 45 minutes and has a low success rate due to the inaccuracy of the application.

Lateral Approach:

This technique attempted to access the SPG with a needle through the jaw joint. This technique is very painful and moderately dangerous. The success was much better but was still inaccurate and inefficient due to cost.

Greater Palatine Foramen Technique:

This technique attempts to access the SPG through the top of the mouth. This technique is very dangerous and painful.

Tx360EU® Nasal Applicator

Studies & Resources
Instructional Videos
Warnings & Precautions
SPG Block - New Approach

Disclaimer:


The information contained in this page
is for European Market only.

Reach us Through the Following

Phone: (855) 338-0042
Fax: (312) 635-0108

Contact us

Your Name (required)

Your Email (required)

Subject

Your Message

Our Location

88 E Belvidere Rd #212, Grayslake, IL 60030